Bildkälla: Stockfoto

Medivir: New Results with MIV-701 - Redeye

Redeye comments on the positive results from a proof-of-concept study with the veterinary candidate VBX-1000 (MIV-701) out-licensed to Vetbiolix.

Redeye comments on the positive results from a proof-of-concept study with the veterinary candidate VBX-1000 (MIV-701) out-licensed to Vetbiolix.
Börsvärldens nyhetsbrev
ANNONSER